12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Loading...
Loading...

Gainers

  • Cellectis CLLS stock rose 171.1% to $2.63 during Wednesday's pre-market session. The company's market cap stands at $146.1 million.
  • Monopar Therapeutics MNPR stock rose 79.3% to $0.77. The market value of their outstanding shares is at $10.9 million.
  • ZyVersa Therapeutics ZVSA stock rose 31.38% to $0.11. The company's market cap stands at $4.6 million.
  • TG Therapeutics TGTX shares moved upwards by 24.96% to $9.66. The company's market cap stands at $1.4 billion. As per the news, the Q3 earnings report came out today.
  • Aldeyra Therapeutics ALDX shares moved upwards by 21.04% to $2.07. The company's market cap stands at $121.2 million.
  • Artelo Biosciences ARTL shares increased by 14.97% to $1.42. The market value of their outstanding shares is at $4.0 million.

Losers

  • Iridex IRIX shares fell 29.9% to $2.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $37.3 million.
  • Tonix Pharmaceuticals TNXP shares declined by 18.67% to $0.48. The market value of their outstanding shares is at $10.4 million.
  • Kintara Therapeutics KTRA stock declined by 12.31% to $0.67. The company's market cap stands at $1.1 million.
  • G1 Therapeutics GTHX stock decreased by 11.82% to $1.46. The company's market cap stands at $75.2 million. As per the news, the Q3 earnings report came out today.
  • Turnstone Biologics TSBX stock decreased by 10.4% to $3.19. The company's market cap stands at $72.8 million.
  • Panbela Therapeutics PBLA shares decreased by 8.21% to $0.75. The market value of their outstanding shares is at $2.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...